Get the Stockscreener App
3.895
0.77%
0.005
After Hours:
3.96
0.065
+1.67%
Evolent Health Inc stock is traded at $3.895, with a volume of 1.84M.
It is up +0.77% in the last 24 hours and up +38.38% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
See More
Previous Close:
$3.90
Open:
$3.91
24h Volume:
1.84M
Relative Volume:
0.60
Market Cap:
$438.11M
Revenue:
$1.88B
Net Income/Loss:
$-534.51M
P/E Ratio:
-0.7566
EPS:
-5.1483
Net Cash Flow:
$4.76M
1W Performance:
-5.53%
1M Performance:
+38.38%
6M Performance:
+11.02%
1Y Performance:
-54.41%
1-Day Range:
$3.80
$4.085
1-Week Range:
$3.80
$4.365
52-Week Range:
$2.095
$12.06
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.895 | 438.68M | 1.88B | -534.51M | 4.76M | -5.1483 |
VEEV
Veeva Systems Inc
|
163.36 | 26.74B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
56.72 | 10.89B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
45.54 | 7.83B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
84.69 | 6.96B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
54.96 | 4.23B | 646.34M | -512.40M | 202.76M | -6.6871 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health Q1 earnings call highlights - MSN
EVH Stock Price Prediction 2025-2026 | Evolent Health Inc Forecast - 24/7 Wall St.
Analysts’ Top Healthcare Picks: ProMIS Neurosciences (PMN), Evolent Health (EVH) - The Globe and Mail
WATER ISLAND CREDIT OPPORTUNITIES FUND's Evolent Health Inc(EVH) Holding History - GuruFocus
Evolent Health to Participate in Upcoming Conferences - GuruFocus
EVH Maintained by Citigroup -- Price Target Raised to $5.50 - GuruFocus
Citigroup Adjusts Price Target on Evolent Health to $5.50 From $4, Maintains Buy Rating - Moomoo
Citi Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $5.5 - Moomoo
EVH Stock Price, Quote & Chart | EVOLENT HEALTH INCA (NYSE:EVH) - ChartMill
Earnings call transcript: Evolent Health Q1 2026 beats EPS, stock surges By Investing.com - Investing.com South Africa
Earnings call transcript: Evolent Health Q1 2026 beats EPS, stock surges - Investing.com UK
Evolent Health Price Target Raised to $6.00/Share From $4.00 by Canaccord Genuity - Moomoo
EVH Maintained by Canaccord Genuity -- Price Target Raised to $6 - GuruFocus
Evolent Health Is Maintained at Buy by Canaccord Genuity - Moomoo
CCORF Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
Canaccord raises Evolent Health stock price target on new wins By Investing.com - Investing.com South Africa
Canaccord raises Evolent Health stock price target on new wins - Investing.com
AI-focused health plan tools get new steward at Quest Analytics - Stock Titan
TD Cowen raises Evolent Health stock price target on recovery track - Investing.com UK
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $8 - Moomoo
TD Cowen raises Evolent Health stock price target on recovery track By Investing.com - Investing.com South Africa
Evolent Health Q1 Earnings Call Highlights - MarketBeat
Evolent Health, Inc (NYSE:EVH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Evolent Health(EVH) Stock Options Chain | Quotes & News - Moomoo
A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $5 to $6 - Moomoo
Evolent Health, Inc. (NYSE:EVH) Just Released Its First-Quarter Earnings: Here's What Analysts Think - simplywall.st
Evolent Health, Inc. (NYSE:EVH) Q1 2026 Earnings Call Transcript - Insider Monkey
Evolent Health Earnings Call Balances Growth and Risk - TipRanks
MSN Money - MSN
A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $5 to $5 - Moomoo
Evolent (EVH) Q1 2026 Earnings Call Transcript - AOL.com
BMO Capital Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
Evolent Health, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Evolent Health Q1 2026 slides: revenue misses forecast, leverage rises By Investing.com - Investing.com Australia
Evolent Health: Q1 Earnings Snapshot - theheraldreview.com
EVH Maintained by Needham -- Price Target Raised to $5.00 - GuruFocus
Evolent Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:EVH) 2026-05-07 - Seeking Alpha
Needham Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $5 - Moomoo
Why is Evolent Health (EVH) stock soaring today - MSN
Why Is Evolent Health (EVH) Stock Soaring Today - TradingView
Earnings call transcript: Evolent Health Q1 2026 beats EPS expectations By Investing.com - Investing.com South Africa
Evolent Health Q1 2026 slides: revenue misses forecast, leverage rises - Investing.com
Earnings call transcript: Evolent Health Q1 2026 beats EPS expectations - Investing.com
Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):